Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration
- 28 March 2003
- journal article
- review article
- Published by Elsevier BV in Virology
- Vol. 308 (1), 1-12
- https://doi.org/10.1016/s0042-6822(02)00091-0
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Immunological Aspects of Rat Models of HTLV Type 1-Infected T Lymphoproliferative DiseaseAIDS Research and Human Retroviruses, 2000
- Repression of Bax Gene Expression by the HTLV-I Tax Protein: Implications for Suppression of Apoptosis in Virally Infected CellsVirology, 1997
- HUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASESAnnual Review of Immunology, 1997
- Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytesAnnals of Neurology, 1996
- Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancerJournal of NeuroVirology, 1995
- Sequence variations in ltr and env regions of HTLV‐I do not discriminate between the virus from patients with HTLV‐I‐associated myelopathy and adult T‐cell leukemiaInternational Journal of Cancer, 1991
- Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological diseaseNature, 1990
- Nationwide survey of HTLV‐I–associated myelopathy in Japan: Association with blood transfusionAnnals of Neurology, 1990
- The tat Gene of Human T-Lymphotropic Virus Type 1 Induces Mesenchymal Tumors in Transgenic MiceScience, 1987
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences of the United States of America, 1980